• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA S.R.L CARBOMEDICS TOP HAT MECHANICAL HEART VALVE; MECHANICAL HEART VALVE PROSTHESIS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA S.R.L CARBOMEDICS TOP HAT MECHANICAL HEART VALVE; MECHANICAL HEART VALVE PROSTHESIS Back to Search Results
Model Number CPHV
Device Problem Insufficient Information (3190)
Patient Problems Corneal Pannus (1447); Aortic Valve Stenosis (1717); No Information (3190)
Event Date 06/14/2017
Event Type  Injury  
Manufacturer Narrative
The manufacturer is in the process of contacting the physician to gather more information on this event.Not yet determined if device available.
 
Event Description
On 14th june the manufacturer was notified through patient tracking of a carbomedics top hat mechanical heart valve s5-021 which was explanted on (b)(6) 2017, after 4.54 years implant duration.A crown prt pericardial heart valve size 21 was then implanted.
 
Manufacturer Narrative
A complete manufacturing and material records review for the device has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.As the device was not available for analysis, no further investigation can be performed.However, based on the document review conducted, no manufacturing deficits were identified.Prosthetic valve dysfunction at the aortic position is commonly caused by pannus formation, an inflammatory response relating to the patient's condition.The exact etiology of pannus formation is not known, but many factors can be involved in its formation.Pannus represents a bioreaction to prosthetic valves associated with coexisting factors such as surgical technique, thrombus organization from inadequate anticoagulation, infection and wall shear stress.Device not available for return.
 
Event Description
On (b)(6) the manufacturer was notified through patient tracking of a carbomedics top hat mechanical heart valve s5-021 which was explanted on (b)(6) 2017, after 4.54 years implant duration.A crown prt pericardial heart valve size 21 was then implanted.The valve was explanted due to prosthetic valve stenosis.The cause of the increased gradient was attributed to pannus.The device is not available for analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARBOMEDICS TOP HAT MECHANICAL HEART VALVE
Type of Device
MECHANICAL HEART VALVE PROSTHESIS
Manufacturer (Section D)
SORIN GROUP ITALIA S.R.L
strada crescentino snc
saluggia,, vc 13040
IT  13040
Manufacturer (Section G)
SORIN GROUP ITALIA S.R.L.
strada crescentino snc
saluggia,, vc
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc 
MDR Report Key6724909
MDR Text Key80435570
Report Number3005687633-2017-00076
Device Sequence Number1
Product Code LWQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P900060
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/20/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/19/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date06/04/2017
Device Model NumberCPHV
Device Catalogue NumberS5-021
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/08/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/05/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age72 YR
-
-